When do dengue IgM and IgG antibodies become detectable after onset of fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dengue IgM and IgG Detection Timeline

Dengue IgM antibodies typically become detectable around day 4-5 after fever onset, while IgG antibodies appear later around day 7-10 in primary infections, but IgG appears much earlier (days 4-6) in secondary infections. 1

Testing Algorithm Based on Days Post-Symptom Onset

Days 0-7 (Acute Phase)

  • Primary testing method: NAAT (nucleic acid testing) or NS1 antigen detection
  • IgM antibody testing: Should be performed on specimens collected >7 days after symptom onset 1
  • Critical caveat: A negative IgM test during days 0-7 does NOT rule out dengue, as antibodies may not yet be detectable 1

Days 7+ (Post-Acute Phase)

  • IgM antibody testing becomes reliable for both primary and secondary infections
  • Specimens collected from 7 days to 12 weeks after onset: a negative IgM result to dengue effectively rules out recent infection 1

Primary vs Secondary Infection Patterns

Primary Dengue Infection

  • IgM detection timeline:

    • Days 1-3: Not detectable 2
    • Days 4-7: Detected in ~55% of cases 2
    • Day 5: Detected in 4 of 5 samples 3
    • Day 6+: Detected in 100% of samples 3
    • After day 7: Detected in 94% of cases 2
  • IgG detection timeline:

    • Days 0-10: Not detected 3
    • Days 12-15: Detected in some samples 3
    • Days 7-10: Begins to appear 1

Secondary Dengue Infection

  • IgM detection timeline:

    • Days 2-3: Not detected 3
    • Days 4-6: Detected in only 20 of 79 samples (25%) 3
    • Days 4-7: Detected in 47% of cases 2
    • Days 7-11: Detected in 44 of 65 samples (68%) 3
    • After day 7: Detected in 78% of cases 2
  • IgG detection timeline:

    • Days 4-5: Detected in 21 of 60 samples (35%) 3
    • Day 6: Detected in 13 of 19 samples (68%) 3
    • Days 7-11: Detected in 62 of 65 samples (95%) 3
    • Day 12+: Detected in 100% of samples 3

Critical Clinical Pearls

The IgM response is significantly blunted in secondary dengue infections - this is the most important diagnostic pitfall. In secondary infections, IgM may be low or even undetectable, while IgG rises rapidly and early (as early as days 4-6) 3, 2. This reflects the anamnestic immune response.

IgM antibodies persist for months: Dengue IgM can remain detectable for 60+ days and potentially up to 12 months after acute infection 1. This means a positive IgM does not necessarily indicate acute infection - clinical correlation with symptom timing is essential.

Optimal testing window: For specimens collected <7 days after symptom onset, combine NAAT/NS1 testing with IgM antibody testing. However, a negative IgM during this period does not exclude infection 1. For specimens collected ≥7 days after onset, IgM antibody testing becomes the primary diagnostic modality.

Practical Testing Recommendations

  • Days 0-5: Use NAAT or NS1 antigen detection as primary test; IgM will likely be negative even in true dengue
  • Days 5-7: Transition period - both NAAT/NS1 and IgM testing should be performed
  • Days 7+: IgM and IgG serology becomes reliable; negative results effectively rule out dengue 1
  • Suspected secondary infection: Look for early IgG positivity (days 4-6) with low/absent IgM as a characteristic pattern 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.